• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Allergan sues Valeant, Ackman for alleged insider trading

















their blood is on your hands


enjoying others pain is not good



karma will get you

No one is enjoying the lay-offs of our fellow employees. You seem to be forgetting the perpetrators in all of this. Would these people be out of work if Pearson/Ackman's greed and lust for power had not come into play? No. They wouldn't.
 
























What do you all want to bet that all, or at least the overwhelming majority of this thread is posted by the same person? Made the original post then every two minutes or so 'responded'! You are so brilliant! Ingenious!

Bore !
 




Pearson is meeting with top Valeant investors on coming Monday and Tuesday. On Thursday 11 million Valeant shares were traded and some investors were selling big time.

Top question will be ... how long Valeant can wait for another acquisition. At the end of the day investors understand that Valeant is an acquisition machine and without new acquisition these investors will move to ENDO which is mini Valeant but more aggressive

SirGene ... you are a genius ... almost like DZ

Pearson met top investors and they dumped the stock ... LOL x LOL